SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-153749
Filing Date
2024-06-04
Accepted
2024-06-04 09:30:01
Documents
13
Period of Report
2024-06-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d825208d8k.htm   iXBRL 8-K 617873
  Complete submission text file 0001193125-24-153749.txt   772554

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avro-20240604.xsd EX-101.SCH 2849
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20240604_lab.xml EX-101.LAB 18736
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20240604_pre.xml EX-101.PRE 11706
16 EXTRACTED XBRL INSTANCE DOCUMENT d825208d8k_htm.xml XML 4060
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 241016244
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)